The Procter & Gamble Company (Procter & Gamble) herewith submits, in triplicate, comments in response to the final rule: labeling of oral and rectal over-the-counter (OTC) drug products containing aspirin and nonaspirin salicylates; Reye’s syndrome warning, published on April 17,2003 in the Federal Register (Vol. 68, No. 74, pages 18861-18869). Procter & Gamble, as a manufacturer and distributo...